Stay updated on Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check4 days agoChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears on the page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe website revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe Record History page now reflects a new software Revision entry (v3.7.0) replacing the previous v3.6.6, indicating a recent site update.SummaryDifference0.1%

- Check54 days agoChange DetectedLatest revision on the Record History page is v3.6.6, replacing the previous v3.6.5. This indicates a small site update rather than changes to the study record or its data.SummaryDifference0.1%

- Check75 days agoChange DetectedThe revision label on the page changed from v3.6.4 to v3.6.5, indicating a newer version of the history display. This is a formatting/version update and does not alter the underlying study information.SummaryDifference0.1%

- Check89 days agoChange Detected- The page history now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor version update to the study record history interface rather than substantive data changes.SummaryDifference0.1%

Stay in the know with updates to Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.